Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Jump To

Sandostatin Dosage

Generic name: octreotide injection
Brand names: Sandostatin, Sandostatin LAR Depot
Drug class: Somatostatin and somatostatin analogs

Medically reviewed by  A Ras MD.

 

 Recommended Adult Dosing

Dosage forms:  INJ: 50 mcg per mL, 100 mcg per mL, 500 mcg per mL

Acromegaly

[50-100 mcg SC/IV tid]
Start: 50 mcg SC/IV tid; Max: 500 mcg/dose; 1500 mcg/day; Info: titrate to serum GH <5 ng/mL w/in 8h after dose or serum IGF-1 <1.9 units/mL (males) or <2.2 units/mL (females) after 2wk from start or dose change; doses >300 mcg/day rarely more effective; monitor GH or IGF-1 at least q6mo; D/C x4wk qy in pts w/ pituitary irradiation to assess disease activity, need for tx

Carcinoid tumor symptoms

[100-600 mcg/day SC/IV divided bid-qid]
Max: 500 mcg/dose; 1500 mcg/day; Info: for pts w/ severe diarrhea or flushing; titrate based on sx response

VIPoma symptoms

[150-750 mcg/day SC/IV divided bid-qid]
Start: 200-300 mcg/day SC/IV divided bid-qid x2wk; Max: 500 mcg/dose; Info: for pts w/ severe diarrhea; titrate based on sx response

Carcinoid crisis, acute

[50-500 mcg IV prn]
Max: 500 mcg/dose; 1500 mcg/day; Alt: 50 mcg/h IV infusion x8-24h

Carcinoid crisis prophylaxis

[250-500 mcg IV x1]
Info: give 1-2h preop

Diarrhea, secretory

[50-1500 mcg/day SC/IV divided qd-tid]
Start: 50 mcg SC/IV bid-tid, then may incr. by 100 mcg/dose q48h; Max: 500 mcg/dose up to 1500 mcg/day; Info: titrate based on response

Esophageal varices

[50 mcg/h IV x5 days]
Start: 50 mcg IV x1; Info: for acute variceal bleeding

Renal dosing

renal impairment: not defined, caution advised
HD: consider decr. usual dose, on dialysis days admin. after dialysis; consider supplement if next maint. dose not due right after dialysis; PD: not defined

Hepatic dosing

[not defined]
hepatic impairment: caution advised

 

SRC: NLM .

Read Next Article